Immune Response to Initial and Booster SARS-CoV-2 mRNA Vaccination in Patients Treated with Siponimod—Final Analysis of a Nonrandomized Controlled Clinical Trial (AMA-VACC)

NIL

Jahr

Publikationsjahr
2023

Autoren

Autorenliste der Publikation
Ziemssen T, Groth M, Winkelmann VE, Bopp T.

Verlag

Publisher-Information
Vaccines. 2023; 11(8):1374.

Link

Zur Publikation (externer Server)
https://doi.org/10.3390/vaccines11081374

Tags

Forschungsthemen
Multiple SkleroseNeuroimmunologieAndere
MSZNIL2023